View in EDS PDF Full Text

Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.

Saved in:
Bibliographic Details
Title: Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
Authors: Ferrari M; Autolus Therapeutics, London, UK., Righi M; Autolus Therapeutics, London, UK., Baldan V; Autolus Therapeutics, London, UK., Wawrzyniecka P; Cardiff University School of Medicine; Heath Park, Cardiff, UK., Bulek A; Autolus Therapeutics, London, UK., Kinna A; Autolus Therapeutics, London, UK., Ma B; Autolus Therapeutics, London, UK., Bughda R; Autolus Therapeutics, London, UK., Akbar Z; Autolus Therapeutics, London, UK., Srivastava S; Autolus Therapeutics, London, UK., Gannon I; Autolus Therapeutics, London, UK., Robson M; Autolus Therapeutics, London, UK., Sillibourne J; Autolus Therapeutics, London, UK., Jha R; Autolus Therapeutics, London, UK., El-Kholy M; Autolus Therapeutics, London, UK., Amin OM; Autolus Therapeutics, London, UK., Kokalaki E; Autolus Therapeutics, London, UK., Banani MA; Autolus Therapeutics, London, UK., Hussain R; Autolus Therapeutics, London, UK., Day W; Autolus Therapeutics, London, UK., Lim WC; Autolus Therapeutics, London, UK., Ghongane P; Autolus Therapeutics, London, UK., Hopkins JR; Cardiff University School of Medicine; Heath Park, Cardiff, UK., Jungherz D; Department of Hematology, Cell Therapy, Hemostaseology, and Infectious Diseases, University of Leipzig Medical Centre, Leipzig, Germany., Herling M; Department of Hematology, Cell Therapy, Hemostaseology, and Infectious Diseases, University of Leipzig Medical Centre, Leipzig, Germany., Welin M; Saromics Inc., Lund, Sweden., Surade S; Iontas Ltd., Pampisford, Cambridge, UK., Dyson M; Iontas Ltd., Pampisford, Cambridge, UK., McCafferty J; Iontas Ltd., Pampisford, Cambridge, UK., Logan D; Saromics Inc., Lund, Sweden., Cordoba S; Autolus Therapeutics, London, UK., Thomas S; Autolus Therapeutics, London, UK., Sewell A; Cardiff University School of Medicine; Heath Park, Cardiff, UK., Maciocia P; Cancer Institute; University College London, London, UK., Onuoha S; Autolus Therapeutics, London, UK., Pule M; Autolus Therapeutics, London, UK. m.pule@ucl.ac.uk.; Cancer Institute; University College London, London, UK. m.pule@ucl.ac.uk.
Source: Nature communications [Nat Commun] 2024 Feb 21; Vol. 15 (1), pp. 1583. Date of Electronic Publication: 2024 Feb 21.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38383515
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ferrari+M%22">Ferrari M</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Righi+M%22">Righi M</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Baldan+V%22">Baldan V</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Wawrzyniecka+P%22">Wawrzyniecka P</searchLink>; Cardiff University School of Medicine; Heath Park, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Bulek+A%22">Bulek A</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Kinna+A%22">Kinna A</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Ma+B%22">Ma B</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Bughda+R%22">Bughda R</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Akbar+Z%22">Akbar Z</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Srivastava+S%22">Srivastava S</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Gannon+I%22">Gannon I</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Robson+M%22">Robson M</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Sillibourne+J%22">Sillibourne J</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Jha+R%22">Jha R</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22El-Kholy+M%22">El-Kholy M</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Amin+OM%22">Amin OM</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Kokalaki+E%22">Kokalaki E</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Banani+MA%22">Banani MA</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Hussain+R%22">Hussain R</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Day+W%22">Day W</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Lim+WC%22">Lim WC</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Ghongane+P%22">Ghongane P</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Hopkins+JR%22">Hopkins JR</searchLink>; Cardiff University School of Medicine; Heath Park, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Jungherz+D%22">Jungherz D</searchLink>; Department of Hematology, Cell Therapy, Hemostaseology, and Infectious Diseases, University of Leipzig Medical Centre, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Herling+M%22">Herling M</searchLink>; Department of Hematology, Cell Therapy, Hemostaseology, and Infectious Diseases, University of Leipzig Medical Centre, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Welin+M%22">Welin M</searchLink>; Saromics Inc., Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Surade+S%22">Surade S</searchLink>; Iontas Ltd., Pampisford, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dyson+M%22">Dyson M</searchLink>; Iontas Ltd., Pampisford, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22McCafferty+J%22">McCafferty J</searchLink>; Iontas Ltd., Pampisford, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Logan+D%22">Logan D</searchLink>; Saromics Inc., Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Cordoba+S%22">Cordoba S</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Thomas+S%22">Thomas S</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Sewell+A%22">Sewell A</searchLink>; Cardiff University School of Medicine; Heath Park, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Maciocia+P%22">Maciocia P</searchLink>; Cancer Institute; University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Onuoha+S%22">Onuoha S</searchLink>; Autolus Therapeutics, London, UK.<br /><searchLink fieldCode="AU" term="%22Pule+M%22">Pule M</searchLink>; Autolus Therapeutics, London, UK. m.pule@ucl.ac.uk.; Cancer Institute; University College London, London, UK. m.pule@ucl.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Feb 21; Vol. 15 (1), pp. 1583. <i>Date of Electronic Publication: </i>2024 Feb 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38383515
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-45854-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1583
    Titles:
      – TitleFull: Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ferrari M
      – PersonEntity:
          Name:
            NameFull: Righi M
      – PersonEntity:
          Name:
            NameFull: Baldan V
      – PersonEntity:
          Name:
            NameFull: Wawrzyniecka P
      – PersonEntity:
          Name:
            NameFull: Bulek A
      – PersonEntity:
          Name:
            NameFull: Kinna A
      – PersonEntity:
          Name:
            NameFull: Ma B
      – PersonEntity:
          Name:
            NameFull: Bughda R
      – PersonEntity:
          Name:
            NameFull: Akbar Z
      – PersonEntity:
          Name:
            NameFull: Srivastava S
      – PersonEntity:
          Name:
            NameFull: Gannon I
      – PersonEntity:
          Name:
            NameFull: Robson M
      – PersonEntity:
          Name:
            NameFull: Sillibourne J
      – PersonEntity:
          Name:
            NameFull: Jha R
      – PersonEntity:
          Name:
            NameFull: El-Kholy M
      – PersonEntity:
          Name:
            NameFull: Amin OM
      – PersonEntity:
          Name:
            NameFull: Kokalaki E
      – PersonEntity:
          Name:
            NameFull: Banani MA
      – PersonEntity:
          Name:
            NameFull: Hussain R
      – PersonEntity:
          Name:
            NameFull: Day W
      – PersonEntity:
          Name:
            NameFull: Lim WC
      – PersonEntity:
          Name:
            NameFull: Ghongane P
      – PersonEntity:
          Name:
            NameFull: Hopkins JR
      – PersonEntity:
          Name:
            NameFull: Jungherz D
      – PersonEntity:
          Name:
            NameFull: Herling M
      – PersonEntity:
          Name:
            NameFull: Welin M
      – PersonEntity:
          Name:
            NameFull: Surade S
      – PersonEntity:
          Name:
            NameFull: Dyson M
      – PersonEntity:
          Name:
            NameFull: McCafferty J
      – PersonEntity:
          Name:
            NameFull: Logan D
      – PersonEntity:
          Name:
            NameFull: Cordoba S
      – PersonEntity:
          Name:
            NameFull: Thomas S
      – PersonEntity:
          Name:
            NameFull: Sewell A
      – PersonEntity:
          Name:
            NameFull: Maciocia P
      – PersonEntity:
          Name:
            NameFull: Onuoha S
      – PersonEntity:
          Name:
            NameFull: Pule M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 02
              Text: 2024 Feb 21
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1